Literature DB >> 23678170

Epstein-Barr virus-encoded microRNA BART15-3p promotes cell apoptosis partially by targeting BRUCE.

Hoyun Choi1, Hanna Lee, Sae Rom Kim, Yong Song Gho, Suk Kyeong Lee.   

Abstract

Epstein-Barr Virus (EBV) generates a variety of viral microRNAs (miRNAs) by processing the BHRF1 and BamHI A rightward (BART) transcripts. BART miRNAs are expressed in all cells latently infected with EBV, but the functions of most BART miRNAs remain unknown. The results of a cell proliferation assay revealed that miR-BART15-3p inhibited cell proliferation. Fluorescence-activated cell sorting following staining with annexin V or propidium iodide showed that miR-BART15-3p promoted apoptosis. Furthermore, the inhibitor for miR-BART15-3p increased cell growth and reduced apoptosis in EBV-infected cells. Using bioinformatic analyses, we predicted that miR-BART15-3p may target the antiapoptotic B-cell lymphoma 2 (BCL2), BCL2L2, DEAD (Asp-Glu-Ala-Asp) box polypeptide 42 (DDX42), and baculovirus inhibitor of apoptosis repeat-containing ubiquitin-conjugating enzyme (BRUCE) mRNAs. The luciferase reporter assay showed that only the 3' untranslated region (UTR) of BRUCE was affected by miR-BART15-3p. Two putative seed-matched sites for miR-BART15-3p were evident on the BRUCE 3' UTR. The results of a mutation study indicated that miR-BART15-3p hybridized only with the first seed-matched site on the BRUCE 3' UTR. miR-BART15-3p downregulated the BRUCE protein in EBV-negative cells, while the inhibitor for miR-BART15-3p upregulated the BRUCE protein in EBV-infected cells without affecting the BRUCE mRNA level. miR-BART15-3p was secreted from EBV-infected gastric carcinoma cells, and the level of miR-BART15-3p was 2- to 16-fold higher in exosomes than in the corresponding cells. Our data suggest that miR-BART15-3p can induce apoptosis partially by inhibiting the translation of the apoptosis inhibitor BRUCE. Further study is warranted to understand the role of miR-BART15-3p in the EBV life cycle.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23678170      PMCID: PMC3700184          DOI: 10.1128/JVI.03159-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

Review 1.  Pathogenic roles for Epstein-Barr virus (EBV) gene products in EBV-associated proliferative disorders.

Authors:  Jaap M Middeldorp; Antoinette A T P Brink; Adriaan J C van den Brule; Chris J L M Meijer
Journal:  Crit Rev Oncol Hematol       Date:  2003-01       Impact factor: 6.312

2.  In vivo transcription of the Epstein-Barr virus (EBV) BamHI-A region without associated in vivo BARF0 protein expression in multiple EBV-associated disorders.

Authors:  Josine van Beek; Antoinette A T P Brink; Marcel B H J Vervoort; Mireille J M van Zijp; Chris J L M Meijer; Adriaan J C van den Brule; Jaap M Middeldorp
Journal:  J Gen Virol       Date:  2003-10       Impact factor: 3.891

3.  Extracellular membrane vesicles from tumor cells promote angiogenesis via sphingomyelin.

Authors:  Chan Woo Kim; Hwan Myung Lee; Tae Hoon Lee; Chulhun Kang; Hynda K Kleinman; Yong Song Gho
Journal:  Cancer Res       Date:  2002-11-01       Impact factor: 12.701

4.  A human IAP-family gene, apollon, expressed in human brain cancer cells.

Authors:  Z Chen; M Naito; S Hori; T Mashima; T Yamori; T Tsuruo
Journal:  Biochem Biophys Res Commun       Date:  1999-11-02       Impact factor: 3.575

5.  Caspase activation is required for permissive replication of Aleutian mink disease parvovirus in vitro.

Authors:  Sonja M Best; James B Wolfinbarger; Marshall E Bloom
Journal:  Virology       Date:  2002-01-20       Impact factor: 3.616

6.  Identification of novel Epstein-Barr virus microRNA genes from nasopharyngeal carcinomas.

Authors:  Jia Yun Zhu; Thorsten Pfuhl; Natalie Motsch; Stephanie Barth; John Nicholls; Friedrich Grässer; Gunter Meister
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

Review 7.  Epstein-Barr virus and oncogenesis: from latent genes to tumours.

Authors:  Lawrence S Young; Paul G Murray
Journal:  Oncogene       Date:  2003-08-11       Impact factor: 9.867

8.  Diverse herpesvirus microRNAs target the stress-induced immune ligand MICB to escape recognition by natural killer cells.

Authors:  Daphna Nachmani; Noam Stern-Ginossar; Ronit Sarid; Ofer Mandelboim
Journal:  Cell Host Microbe       Date:  2009-04-23       Impact factor: 21.023

9.  Comprehensive profiling of Epstein-Barr virus microRNAs in nasopharyngeal carcinoma.

Authors:  Katherine Cosmopoulos; Michiel Pegtel; Jared Hawkins; Howell Moffett; Carl Novina; Jaap Middeldorp; David A Thorley-Lawson
Journal:  J Virol       Date:  2008-12-17       Impact factor: 5.103

10.  Caspase cleavage of the nonstructural protein NS1 mediates replication of Aleutian mink disease parvovirus.

Authors:  Sonja M Best; Janie F Shelton; Justine M Pompey; James B Wolfinbarger; Marshall E Bloom
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

View more
  50 in total

1.  Plasma EBV microRNAs in paediatric renal transplant recipients.

Authors:  Jaythoon Hassan; Jonathan Dean; Cillian F De Gascun; Michael Riordan; Clodagh Sweeney; Jeff Connell; Atif Awan
Journal:  J Nephrol       Date:  2017-11-28       Impact factor: 3.902

Review 2.  Small RNA as a regulator of hematopoietic development, immune response in infection and tumorigenesis.

Authors:  Kazuki Okuyama; Jun Ogata; Natsuko Yamakawa; Bidisha Chanda; Ai Kotani
Journal:  Int J Hematol       Date:  2014-04-01       Impact factor: 2.490

3.  EBV-miR-BART12 inhibits cell migration and proliferation by targeting Snail expression in EBV-associated gastric cancer.

Authors:  Jun Li; Yan Zhang; Juanjuan Liu; Qianzhu Shi; Wen Liu; Bing Luo
Journal:  Arch Virol       Date:  2021-03-01       Impact factor: 2.574

4.  Profiling of Virus-Encoded MicroRNAs in Epstein-Barr Virus-Associated Gastric Carcinoma and Their Roles in Gastric Carcinogenesis.

Authors:  Aya Shinozaki-Ushiku; Akiko Kunita; Maya Isogai; Takashi Hibiya; Tetsuo Ushiku; Kenzo Takada; Masashi Fukayama
Journal:  J Virol       Date:  2015-03-04       Impact factor: 5.103

Review 5.  Revisiting Regulated Cell Death Responses in Viral Infections.

Authors:  Devasahayam Arokia Balaya Rex; Thottethodi Subrahmanya Keshava Prasad; Richard K Kandasamy
Journal:  Int J Mol Sci       Date:  2022-06-24       Impact factor: 6.208

Review 6.  Multiple functions are mediated by the miRNAs of Epstein-Barr virus.

Authors:  Malika Kuzembayeva; Mitchell Hayes; Bill Sugden
Journal:  Curr Opin Virol       Date:  2014-05-10       Impact factor: 7.090

Review 7.  Exosomal miRNAs: novel players in viral infection.

Authors:  Javid Sadri Nahand; Maryam Mahjoubin-Tehran; Mohsen Moghoofei; Mohammad Hossein Pourhanifeh; Hamid Reza Mirzaei; Zatollah Asemi; Alireza Khatami; Farah Bokharaei-Salim; Hamed Mirzaei; Michael R Hamblin
Journal:  Epigenomics       Date:  2020-02-25       Impact factor: 4.778

8.  Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.

Authors:  Z Zeng; S Fan; X Zhang; S Li; M Zhou; W Xiong; M Tan; W Zhang; G Li
Journal:  Clin Transl Oncol       Date:  2015-08-11       Impact factor: 3.405

9.  Epstein-Barr Virus MicroRNA miR-BART5-3p Inhibits p53 Expression.

Authors:  Xiang Zheng; Jia Wang; Lingyu Wei; Qiu Peng; Yingxue Gao; Yuxin Fu; Yuanjun Lu; Zailong Qin; Xuemei Zhang; Jianhong Lu; Chunlin Ou; Zhengshuo Li; Xiaoyue Zhang; Peishan Liu; Wei Xiong; Guiyuan Li; Qun Yan; Jian Ma
Journal:  J Virol       Date:  2018-11-12       Impact factor: 5.103

10.  Gold nano-particles (AuNPs) carrying anti-EBV-miR-BART7-3p inhibit growth of EBV-positive nasopharyngeal carcinoma.

Authors:  Longmei Cai; Jinbang Li; Xiaona Zhang; Yaoyong Lu; Jianguo Wang; Xiaoming Lyu; Yuxiang Chen; Jinkun Liu; Hongbing Cai; Ying Wang; Xin Li
Journal:  Oncotarget       Date:  2015-04-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.